Bryn Mawr Trust CO Astrazeneca PLC Transaction History
Bryn Mawr Trust CO
- $5.44 Billion
- Q4 2024
A detailed history of Bryn Mawr Trust CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Bryn Mawr Trust CO holds 75,651 shares of AZN stock, worth $5.72 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
75,651
Previous 71,647
5.59%
Holding current value
$5.72 Million
Previous $5.58 Million
11.21%
% of portfolio
0.09%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.57 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.1 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.84 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.8 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.82 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $234B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...